The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Lloyd-smith Malcolm since 2013.
This trader's CIK number is 1557146.
At the time of last reporting, Lloyd-smith Malcolm was the Chief Integration Officer of Neurocrine Biosciences Inc. (stock ticker symbol NBIX).
Also see all insider trading activities at Neurocrine Biosciences Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2013 | CADX | 0 | $0 | 18,000 | $139,660 | 14,000 | $49,140 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | NBIX | 0 | $0 | 16,984 | $1,754,013 | 0 | $0 |
| 2022 | NBIX | 0 | $0 | 24,915 | $2,553,495 | 29,576 | $1,205,859 |
| 2021 | NBIX | 0 | $0 | 41,205 | $4,490,878 | 20,370 | $715,546 |
| 2020 | NBIX | 0 | $0 | 39,870 | $4,151,284 | 28,969 | $1,658,185 |
| 2019 | NBIX | 0 | $0 | 12,148 | $1,093,492 | 9,956 | $153,820 |
| 2018 | NBIX | 0 | $0 | 28,044 | $2,471,775 | 27,084 | $418,447 |
| 2017 | NBIX | 0 | $0 | 23,868 | $1,234,661 | 9,960 | $153,882 |
| 2016 | NBIX | 0 | $0 | 9,000 | $450,000 | 9,000 | $139,050 |
1. Cadence Pharmaceuticals Inc (CADX)
2. Neurocrine Biosciences Inc (NBIX)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2013-07-22 | CADX | Option Ex | 14,000 | 3.51 | 49,140 |
| 2013-07-22 | CADX | Sale | 14,000 | 7.85 | 109,900 |
| 2013-06-10 | CADX | Sale | 4,000 | 7.44 | 29,760 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-02-07 | NBIX | Sale | 13,816 | 102.29 | 1,413,183 |
| 2023-02-08 | NBIX | Sale | 701 | 103.83 | 72,784 |
| 2023-02-06 | NBIX | Sale | 801 | 105.81 | 84,757 |
| 2023-01-31 | NBIX | Sale | 1,666 | 110.02 | 183,289 |
| 2022-08-15 | NBIX | Option Ex | 8,043 | 53.57 | 430,887 |
| 2022-08-12 | NBIX | Sale | 21,533 | 105.95 | 2,281,335 |
| 2022-08-12 | NBIX | Option Ex | 21,533 | 35.99 | 774,972 |
| 2022-02-07 | NBIX | Sale | 2,681 | 80.72 | 216,410 |
| 2022-02-08 | NBIX | Sale | 701 | 79.53 | 55,750 |
| 2021-07-27 | NBIX | Sale | 16,709 | 93.80 | 1,567,337 |
| 2021-02-10 | NBIX | Option Ex | 1,700 | 35.99 | 61,183 |
| 2021-02-10 | NBIX | Sale | 1,700 | 119.96 | 203,925 |
| 2021-02-08 | NBIX | Sale | 3,261 | 116.83 | 380,989 |
| 2021-02-05 | NBIX | Sale | 865 | 114.15 | 98,738 |
| 2021-01-25 | NBIX | Option Ex | 17,570 | 34.99 | 614,774 |
| 2021-01-26 | NBIX | Option Ex | 1,100 | 35.99 | 39,589 |
| 2021-01-25 | NBIX | Sale | 17,570 | 119.97 | 2,107,925 |
| 2021-01-26 | NBIX | Sale | 1,100 | 119.97 | 131,964 |
| 2020-11-12 | NBIX | Sale | 2,257 | 90.73 | 204,775 |
| 2020-08-05 | NBIX | Sale | 2,257 | 118.86 | 268,278 |
| 2020-04-24 | NBIX | Sale | 1,934 | 99.45 | 192,328 |
| 2020-02-07 | NBIX | Sale | 1,015 | 103.28 | 104,826 |
| 2020-02-10 | NBIX | Option Ex | 28,969 | 57.24 | 1,658,185 |
| 2020-02-10 | NBIX | Sale | 28,969 | 104.56 | 3,029,085 |
| 2020-02-05 | NBIX | Sale | 1,948 | 103.05 | 200,735 |
| 2020-02-06 | NBIX | Sale | 1,490 | 101.52 | 151,257 |
| 2019-10-14 | NBIX | Option Ex | 9,956 | 15.45 | 153,820 |
| 2019-10-14 | NBIX | Sale | 9,956 | 90.85 | 904,482 |
| 2019-02-06 | NBIX | Sale | 920 | 83.58 | 76,893 |
| 2019-02-05 | NBIX | Sale | 1,272 | 88.14 | 112,117 |
| 2018-11-07 | NBIX | Sale | 3,300 | 110.00 | 363,000 |
| 2018-11-06 | NBIX | Sale | 5,700 | 110.02 | 627,096 |
| 2018-11-07 | NBIX | Option Ex | 3,300 | 15.45 | 50,985 |
| 2018-11-06 | NBIX | Option Ex | 5,700 | 15.45 | 88,065 |
| 2018-02-05 | NBIX | Sale | 960 | 83.19 | 79,862 |
| 2018-01-02 | NBIX | Sale | 18,084 | 77.52 | 1,401,817 |
| 2018-01-02 | NBIX | Option Ex | 18,084 | 15.45 | 279,397 |
| 2017-05-18 | NBIX | Option Ex | 4,980 | 15.45 | 76,941 |
| 2017-05-19 | NBIX | Option Ex | 4,980 | 15.45 | 76,941 |
| 2017-05-18 | NBIX | Sale | 4,980 | 53.26 | 265,234 |
| 2017-05-19 | NBIX | Sale | 4,980 | 54.00 | 268,920 |
| 2017-04-12 | NBIX | Sale | 13,065 | 50.82 | 663,963 |
| 2017-02-07 | NBIX | Sale | 116 | 44.61 | 5,174 |
| 2017-02-06 | NBIX | Sale | 727 | 43.15 | 31,370 |
| 2016-09-01 | NBIX | Option Ex | 9,000 | 15.45 | 139,050 |
| 2016-09-01 | NBIX | Sale | 9,000 | 50.00 | 450,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Lloyd-smith Malcolm (Chief Integration Officer of Neurocrine Biosciences Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.